Normalized FeNO Raised FeNO p-value
n 35 15
Age 57.2 ± 12.5 46.7 ± 15.5 0.15
Gender (Female) 16 (45.7%) 7 (46.7%) 0.95
BMI (Kg/m2) 30.7 ± 4.6 32.5 ± 6.2 0.15
Atopy - yes (%) 12 (40.0%) 13 (92.9%) <0.01
Chronic Rhinosinusitis - yes (%) 20 (66.7%) 8 (57.1%) 0.54
Nasal polyps - yes (%) 14 (46.7%) 7 (50.0%) 0.84
Bronchiectasis - yes (%) 2 (6.7%) 0 (0.0%) 0.32
ACQ post treatment 1.4 ± 1.1 1.7 ± 0.9 0.36
ACQ decrease post treatment -0.7 ± 1.2 - 0.6 ± 1.1 0.68
Blood eosinophils pre treatment 0.4 [0.2 - 0.7] 0.3 [0.1 - 0.8] 0.70
Blood eosinophils post treatment 0.0 [0.0 - 0.02] 0.0 [0.0 - 0.15] 0.10
Sputum eosinophils pre treatment 7.5 [1.5 - 31.1] 18.3 [6.7 - 58.8] 0.17
Sputum eosinophils post treatment 0.0 [0.0 - 0.5] 0.0 [0.0 - 9.2] 0.08
ICS dose post treatment (mcg/day) 1250 [1000 - 2000] 1000 [625 - 1750] 0.32
OCS dose post treatment (mg/day) 5.0 [0.0 - 10.0] 6.3 [0.0 - 10.6] 0.79
FEV1 increase post treatment 0.16 ± 0.41 0.13 ± 0.54 0.30